NCT07402616 2026-02-11
Ex Vivo Cutaneous SCC
Rigshospitalet, Denmark
Phase NA Recruiting
Clinical Trials
5 trialsNCT04154943 2025-12-23
Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 2 Completed
NCT03969004 2025-09-19
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals
Phase 3 Active not recruiting
NCT04339062 2025-04-23
CONTRAC
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT05377905 2025-04-11
cSCC
University of Pittsburgh
Phase 1/2 Recruiting